- AuthorisedPhase II and Phase III (Integrated)
Durability of Immunity induced by the Ebolavirus Vaccine VSV-EBOV and Assessment of a Booster Dose for Pre-Exposure Prophylaxis in Individuals at Potential Occupational Risk for Ebolavirus Exposure: a German Multicenter Study (PREPARE-Germany)
This study looks at how long protection from the Ebola vaccine (Ervebo) lasts in people who might be exposed to the virus at work. It also checks if a booster shot helps. Researchers will follow adults in Germany for two years.
For: Ebola virus infectionGermany - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine when Administered to Healthy Infants
This study is testing a new vaccine that aims to protect babies from serious illnesses like meningitis. The main goals are to see if it's safe, how well babies tolerate it, and if it helps their bodies build protection against these infections.
For: Infections · MeningococcalPoland · Spain · Germany